These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22155032)

  • 1. Characterization of [11C]RO5013853, a novel PET tracer for the glycine transporter type 1 (GlyT1) in humans.
    Wong DF; Ostrowitzki S; Zhou Y; Raymont V; Hofmann C; Borroni E; Kumar A; Parkar N; Brašić JR; Hilton J; Dannals RF; Martin-Facklam M
    Neuroimage; 2013 Jul; 75():282-290. PubMed ID: 22155032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-clinical characterization of [11C]R05013853 as a novel radiotracer for imaging of the glycine transporter type 1 by positron emission tomography.
    Borroni E; Zhou Y; Ostrowitzki S; Alberati D; Kumar A; Hainzl D; Hartung T; Hilton J; Dannals RF; Wong DF
    Neuroimage; 2013 Jul; 75():291-300. PubMed ID: 22178811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycine transporter type 1 occupancy by bitopertin: a positron emission tomography study in healthy volunteers.
    Martin-Facklam M; Pizzagalli F; Zhou Y; Ostrowitzki S; Raymont V; Brašić JR; Parkar N; Umbricht D; Dannals RF; Goldwater R; Wong DF
    Neuropsychopharmacology; 2013 Feb; 38(3):504-12. PubMed ID: 23132267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the novel GlyT1 PET tracer [18F]MK-6577 in humans.
    Joshi AD; Sanabria-Bohórquez SM; Bormans G; Koole M; De Hoon J; Van Hecken A; Depre M; De Lepeleire I; Van Laere K; Sur C; Hamill TG
    Synapse; 2015 Jan; 69(1):33-40. PubMed ID: 25196464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of two glycine transporter 1 radiotracers [11C]GSK931145 and [18F]MK-6577 in baboons.
    Zheng MQ; Lin SF; Holden D; Naganawa M; Ropchan JR; Najafzaden S; Kapinos M; Tabriz M; Carson RE; Hamill TG; Huang Y
    Synapse; 2016 Mar; 70(3):112-20. PubMed ID: 26671330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel radioligand for glycine transporter 1: characterization and use in autoradiographic and in vivo brain occupancy studies.
    Zeng Z; O'Brien JA; Lemaire W; O'Malley SS; Miller PJ; Zhao Z; Wallace MA; Raab C; Lindsley CW; Sur C; Williams DL
    Nucl Med Biol; 2008 Apr; 35(3):315-25. PubMed ID: 18355687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of the glycine transporter 1 in rhesus monkey brain using [18F]MK-6577 and a model-based input function.
    Sanabria-Bohórquez SM; Joshi AD; Holahan M; Daneker L; Riffel K; Williams M; Li W; Cook JJ; Hamill TG
    Neuroimage; 2012 Feb; 59(3):2589-99. PubMed ID: 21930214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and evaluation of [11C]GSK931145 as a novel ligand for imaging the type 1 glycine transporter with positron emission tomography.
    Passchier J; Gentile G; Porter R; Herdon H; Salinas C; Jakobsen S; Audrain H; Laruelle M; Gunn RN
    Synapse; 2010 Jul; 64(7):542-9. PubMed ID: 20196141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 11C-GSK189254 as a novel radioligand for the H3 receptor in humans using PET.
    Ashworth S; Rabiner EA; Gunn RN; Plisson C; Wilson AA; Comley RA; Lai RY; Gee AD; Laruelle M; Cunningham VJ
    J Nucl Med; 2010 Jul; 51(7):1021-9. PubMed ID: 20554726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Test-retest reliability of the novel 5-HT1B receptor PET radioligand [11C]P943.
    Saricicek A; Chen J; Planeta B; Ruf B; Subramanyam K; Maloney K; Matuskey D; Labaree D; Deserno L; Neumeister A; Krystal JH; Gallezot JD; Huang Y; Carson RE; Bhagwagar Z
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):468-77. PubMed ID: 25427881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple and rapid quantification of serotonin transporter binding using [
    Gryglewski G; Rischka L; Philippe C; Hahn A; James GM; Klebermass E; Hienert M; Silberbauer L; Vanicek T; Kautzky A; Berroterán-Infante N; Nics L; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Kasper S; Lanzenberger R
    Neuroimage; 2017 Apr; 149():23-32. PubMed ID: 28119137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retest imaging of [11C]NOP-1A binding to nociceptin/orphanin FQ peptide (NOP) receptors in the brain of healthy humans.
    Lohith TG; Zoghbi SS; Morse CL; Araneta MD; Barth VN; Goebl NA; Tauscher JT; Pike VW; Innis RB; Fujita M
    Neuroimage; 2014 Feb; 87():89-95. PubMed ID: 24225488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translational characterization of [11C]GSK931145, a PET ligand for the glycine transporter type 1.
    Gunn RN; Murthy V; Catafau AM; Searle G; Bullich S; Slifstein M; Ouellet D; Zamuner S; Herance R; Salinas C; Pardo-Lozano R; Rabiner EA; Farre M; Laruelle M
    Synapse; 2011 Dec; 65(12):1319-32. PubMed ID: 21688322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between glycine transporter 1 occupancy and the effects of the glycine transporter 1 inhibitor RG1678 or ORG25935 on object retrieval performance in scopolamine impaired rhesus monkey.
    Eddins D; Hamill TG; Puri V; Cannon CE; Vivian JA; Sanabria-Bohórquez SM; Cook JJ; Morrow JA; Thomson F; Uslaner JM
    Psychopharmacology (Berl); 2014 Feb; 231(3):511-9. PubMed ID: 24051602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-in-Human Assessment of the Novel PDE2A PET Radiotracer 18F-PF-05270430.
    Naganawa M; Waterhouse RN; Nabulsi N; Lin SF; Labaree D; Ropchan J; Tarabar S; DeMartinis N; Ogden A; Banerjee A; Huang Y; Carson RE
    J Nucl Med; 2016 Sep; 57(9):1388-95. PubMed ID: 27103022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodistribution and radiation dosimetry of the glycine transporter-1 ligand 11C-GSK931145 determined from primate and human whole-body PET.
    Bullich S; Slifstein M; Passchier J; Murthy NV; Kegeles LS; Kim JH; Xu X; Gunn RN; Herance R; Gispert JD; Gutiérrez A; Farré M; Laruelle M; Catafau AM
    Mol Imaging Biol; 2011 Aug; 13(4):776-84. PubMed ID: 20730499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vivo Evaluation of
    Zhou X; Boellaard R; Ishiwata K; Sakata M; Dierckx RAJO; de Jong JR; Nishiyama S; Ohba H; Tsukada H; de Vries EFJ; Elsinga PH
    J Nucl Med; 2017 May; 58(5):762-767. PubMed ID: 28062599
    [No Abstract]   [Full Text] [Related]  

  • 18. ¹¹C-ORM-13070, a novel PET ligand for brain α₂C-adrenoceptors: radiometabolism, plasma pharmacokinetics, whole-body distribution and radiation dosimetry in healthy men.
    Luoto P; Suilamo S; Oikonen V; Arponen E; Helin S; Herttuainen J; Hietamäki J; Holopainen A; Kailajärvi M; Peltonen JM; Rouru J; Sallinen J; Scheinin M; Virta J; Virtanen K; Volanen I; Roivainen A; Rinne JO
    Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1947-56. PubMed ID: 24838249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial Evaluation of an Adenosine A
    Sakata M; Ishibashi K; Imai M; Wagatsuma K; Ishii K; Zhou X; de Vries EFJ; Elsinga PH; Ishiwata K; Toyohara J
    J Nucl Med; 2017 Sep; 58(9):1464-1470. PubMed ID: 28280214
    [No Abstract]   [Full Text] [Related]  

  • 20. A human [(11)C]T-773 PET study of PDE10A binding after oral administration of TAK-063, a PDE10A inhibitor.
    Takano A; Stenkrona P; Stepanov V; Amini N; Martinsson S; Tsai M; Goldsmith P; Xie J; Wu J; Uz T; Halldin C; Macek TA
    Neuroimage; 2016 Nov; 141():10-17. PubMed ID: 27423256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.